JolliFos™ (Miltefosine) 100 Capsules 50 mg

JolliFos™ (Miltefosine) Capsules 50 mg

JolliFos™ is an antiparasitic medicinal product for oral administration containing miltefosine. It is indicated for the treatment of leishmaniasis and is one of the few effective oral therapies available for this disease.

Miltefosine shows activity against various Leishmania species and is used in clinical practice in accordance with international treatment guidelines.

Active Substance

• Miltefosine — 50 mg per capsule

Indications

JolliFos™ is used for the treatment of:

• visceral leishmaniasis
• cutaneous leishmaniasis
• mucocutaneous leishmaniasis
  (depending on pathogen susceptibility and clinical guidelines)

Mode of Action

Miltefosine disrupts cell membrane integrity and metabolic processes of Leishmania parasites, leading to parasite death and infection control.

Dosage Form

• Oral capsules
• Strength: 50 mg
• Supplied in blister packs within a carton box

Key Features

• Oral alternative to injectable antiparasitic therapies
• Suitable for outpatient treatment
• Used in tropical disease treatment programs
• Requires strict adherence to prescribed treatment regimens

Manufacturer

Jolly Healthcare Pvt. Ltd.
India